All In Against Cancer Ochsner Cancer Institute

Bladder cancer is one of the most common cancer diagnoses in the United States.  In this episode of the All In Against Cancer podcast powered by the Ochsner Cancer Institute, host Dr. Jonathan Mizrahi talks with Ochsner medical oncologist, Dr. Brian Halbert, and Ochsner urologist, Dr. Ro Arcot, about bladder cancer.  Tune in to hear more about the approach to diagnosis, staging, treatment and prevention of bladder cancer.

Breast cancer is the most common cancer diagnosis in women in the United States and currently accounts for the second most cancer deaths in women behind lung cancer.  More than 260,000 diagnoses of breast cancer are made each year in this country. Advances in screening techniques and identifying who may be at higher risk for the development of breast cancer has allowed us to provide more targeted screening recommendations for our patients. 
In this episode of the All In Against Cancer podcast, we talk with Ochsner breast oncology nurse practitioners Erica Doubleday and Peggy Jo Alker to learn more the importance of and services provided by Ochsner’s high risk breast cancer clinic.

Breast cancer is the most common cancer diagnosis in women in the United States and currently accounts for the second most cancer deaths in women behind lung cancer.  More than 260,000 diagnoses of breast cancer are made each year in this country, and the majority of these are found at an early enough stage that surgery is a preferred option.   
In this episode of the All In Against Cancer podcast, we talk with Ochsner breast surgeon, Dr. Alexa Elder, and plastic surgeon, Dr. Christopher Smith, to learn more about the different types of breast cancer surgeries and how surgical decisions are made in collaboration with patients.

Neuroendocrine tumors represent an uncommon type of cancer that is best managed with a multidisciplinary approach by experts in this disease.  There is a wide range of tumor aggressiveness, prognosis, and potential treatment options which largely depends on how the cancer cells appear under the microscope.  
In this episode of the All In Against Cancer podcast powered by the Ochsner Cancer Institute, host Dr. Jonathan Mizrahi talks with Ochsner medical oncologist, Dr. Lingling Du, and Ochsner interventional radiologist, Dr. Andrew Marsala, about neuroendocrine tumors.  Both Dr. Du and Dr. Marsala specialize in the management of neuroendocrine tumors and are members of the Ochsner Neuroendocrine Tumor Team.
Tune in to hear more about the approach to diagnosis and treatment of neuroendocrine tumors.

Liver cancer is one of the most common types of cancer worldwide and represents the third most common cause of cancer-related death globally. About 75% of liver cancers arise from the liver cells – and these cancers are called hepatocellular carcinoma, or HCC.  The majority of the remaining liver cancers arise from the bile ducts that traverse the liver- and these cancers are referred to biliary tract cancers, or cholangiocarcinoma.
In this episode of the All In Against Cancer podcast powered by the Ochsner Cancer Institute, host Dr. Jonathan Mizrahi talks with Ochsner medical oncologist, Dr. Lingling Du, and Ochsner interventional radiologist, Dr. Tyler Sandow, about liver cancer.
Tune in to hear more about the approach to diagnosis, staging, treatment, prevention, and screening for liver cancer.

Prostate cancer is the second most common cancer in males in the United States with almost a quarter of a million men diagnosed each year.  Advances in surgical and radiation techniques have improved the treatment landscape for patients with localized disease, and novel therapies have allowed us to make headway in our management of those with advanced prostate cancer. 
In this episode of the All In Against Cancer podcast powered by the Ochsner Cancer Institute, host Dr. Jonathan Mizrahi talks with Ochsner medical oncologist, Dr. Zoe Larned, and Ochsner urologist, Dr. Sean Collins, about prostate cancer.
Tune in to hear more about the approach to diagnosis, staging, treatment, prevention, and screening for prostate cancer.